migraine headaches. Migraine
Conditions
Interventions
Intervention 1: Management group: In this group Atorvastatin 40mg tablets from Abidi company, once a day and Nortriptyline 25mg tablets from Abidi company, once a day for 24 days will be used and afte
from Yazd University of Medical Sciences laboratory, once daily and Nortriptyline 25mg tablets from Abidi company once a day, for 24 days will be used your and after 4, 14 and 24 week use a visit and
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 18 to 65 years old Having at least 3 migraine attacks per month Patients who have fewer than three attacks per month Provided that the severity of the attacks is high and affects the person's life. Having a normal serum level of vitamin D3 Sufficient literacy to understand the study, use of medication and possible side effects
Exclusion criteria
Exclusion criteria: Patients who do not sign a moral consent form. Patients with chronic headaches (more than 15 attacks per month). Patients receiving statin due to other diseases, such as diabetes, dyslipidemia, coronary artery disease, peripheral vascular disease, etc. Patients with severe renal insufficiency (GFR <30 ml / min) Failure to co-operate to continue treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of migraine headache attacks. Timepoint: 24 weeks after the start of the study. Method of measurement: Number of attacks in a month based on patient statements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoya Rahmany
Yazd University of Medical Sciences
Outcome results
None listed